Links

            http://www.cancer.gov/cancertopics/types/lung  (NCI website)

            http://www.chestjournal.org/content/vol123/1_suppl/  (ACCP guidelines)

^5-16

Reference List

   1.   Bunn, P. A., Jr. and N. Thatcher. 2008. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion
2. Oncologist. 13 Suppl 1:37-46.

   2.   Fong, T., D. Morgensztern, and R. Govindan. 2008. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
1. J.Thorac.Oncol. 3:303-310.

   3.   Tournoy, K. G., R. F. De, L. R. Vanwalleghem, F. Vermassen, M. Praet, J. G. Aerts, M. G. Van, and J. P. van Meerbeeck. 2008. Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial
3. Am.J.Respir.Crit Care Med. 177:531-535.

   4.   Sher, T., G. K. Dy, and A. A. Adjei. 2008. Small cell lung cancer
1. Mayo Clin.Proc. 83:355-367.

   5.   Wheatley-Price, P., K. Ding, L. Seymour, G. M. Clark, and F. A. Shepherd. 2008. Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
1. J.Clin.Oncol. 26:2350-2357.

   6.   Ladanyi, M. and W. Pao. 2008. Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
2. Mod.Pathol. 21 Suppl 2:S16-S22.

   7.   Sequist, L. V., R. G. Martins, D. Spigel, S. M. Grunberg, A. Spira, P. A. Janne, V. A. Joshi, D. McCollum, T. L. Evans, A. Muzikansky, G. L. Kuhlmann, M. Han, J. S. Goldberg, J. Settleman, A. J. Iafrate, J. A. Engelman, D. A. Haber, B. E. Johnson, and T. J. Lynch. 2008. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations
1. J.Clin.Oncol. 26:2442-2449.

   8.   Molina, J. R., P. Yang, S. D. Cassivi, S. E. Schild, and A. A. Adjei. 2008. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
1. Mayo Clin.Proc. 83:584-594.

   9.   Nici, L. 2008. Preoperative and postoperative pulmonary rehabilitation in lung cancer patients
1. Thorac.Surg.Clin. 18:39-43.

10.   Henschke, C. I. 2007. Survival of patients with clinical stage I lung cancer diagnosed by computed tomography screening for lung cancer
1. Clin.Cancer Res. 13:4949-4950.

11.   Heffner, J. E. 2008. Diagnosis and management of malignant pleural effusions. Respirology. 13:5-20.

12.   Simon, G. R. and A. Turrisi. 2007. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
4. Chest 132:324S-339S.

13.   Arenberg, D. 2007. Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
1. Chest 132:306S-313S.

14.   Herth, F. J., R. Eberhardt, M. Krasnik, and A. Ernst. 2008. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer
5. Chest 133:887-891.

15.   Zimmermann, F. B., H. Geinitz, S. Schill, A. Grosu, U. Schratzenstaller, M. Molls, and B. Jeremic. 2005. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48:107-114.

16.   Bach, P. B., G. A. Silvestri, M. Hanger, and J. R. Jett. 2007. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)
2. Chest 132:69S-77S.